Rhenman & Partners Asset Management’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.7M | Sell |
34,500
-2,346
| -6% | -$1.02M | 1.3% | 32 |
|
|
2026
Q1 | $17M | Sell |
36,846
-11,154
| -23% | -$5.64M | 2.1% | 11 |
|
|
2025
Q4 | $27.2M | Sell |
48,000
-500
| -1% | -$266K | 2.54% | 5 |
|
|
2025
Q3 | $21.7M | Buy |
48,500
+4,150
| +9% | +$1.99M | 2.4% | 6 |
|
|
2025
Q2 | $24.1M | Sell |
44,350
-7,150
| -14% | -$3.74M | 3.05% | 5 |
|
|
2025
Q1 | $25.5M | Sell |
51,500
-12,500
| -20% | -$6.91M | 2.93% | 9 |
|
|
2024
Q4 | $33.4M | Buy |
64,000
+1,000
| +2% | +$521K | 3.43% | 4 |
|
|
2024
Q3 | $31M | Buy |
63,000
+2,500
| +4% | +$1.16M | 2.51% | 11 |
|
|
2024
Q2 | $26.9M | Buy |
60,500
+10,000
| +20% | +$3.98M | 2.58% | 10 |
|
|
2024
Q1 | $20.2M | Sell |
50,500
-13,000
| -20% | -$4.91M | 1.91% | 21 |
|
|
2023
Q4 | $21.4M | Sell |
63,500
-4,000
| -6% | -$1.19M | 2.14% | 14 |
|
|
2023
Q3 | $19.7M | Buy |
67,500
+23,500
| +53% | +$7.34M | 2.13% | 18 |
|
|
2023
Q2 | $15M | Buy |
44,000
+34,000
| +340% | +$10.3M | 1.59% | 28 |
|
|
2023
Q1 | $2.51M | Buy |
10,000
+5,000
| +100% | +$1.23M | 0.28% | 73 |
|
|
2022
Q4 | $1.33M | Sell |
5,000
-45,000
| -90% | -$11M | 0.14% | 88 |
|
|
2022
Q3 | $12.3M | Sell |
50,000
-20,000
| -29% | -$4.3M | 1.29% | 32 |
|
|
2022
Q2 | $14.1M | Buy |
70,000
+17,500
| +33% | +$4.11M | 1.6% | 20 |
|
|
2022
Q1 | $15.8M | Buy |
52,500
+12,500
| +31% | +$3.65M | 1.56% | 26 |
|
|
2021
Q4 | $14.5M | Sell |
40,000
-20,000
| -33% | -$6.88M | 0.97% | 39 |
|
|
2021
Q3 | $19.9M | Sell |
60,000
-7,500
| -11% | -$2.52M | 1.4% | 26 |
|
|
2021
Q2 | $20.7M | Sell |
67,500
-19,500
| -22% | -$5.47M | 1.4% | 27 |
|
|
2021
Q1 | $21.4M | Buy |
87,000
+66,000
| +314% | +$16.6M | 1.49% | 26 |
|
|
2020
Q4 | $5.73M | Sell |
21,000
-15,000
| -42% | -$3.72M | 0.47% | 63 |
|
|
2020
Q3 | $8.51M | Sell |
36,000
-15,000
| -29% | -$3.37M | 0.76% | 50 |
|
|
2020
Q2 | $9.69M | Sell |
51,000
-18,000
| -26% | -$3.23M | 1.05% | 38 |
|
|
2020
Q1 | $11.4M | Buy |
69,000
+33,000
| +92% | +$6.04M | 1.6% | 24 |
|
|
2019
Q4 | $7.09M | Buy |
+36,000
| New | +$6.74M | 0.78% | 53 |
|
|
2017
Q2 | – | Sell |
-36,000
| Closed | -$3.07M | – | 110 |
|
|
2017
Q1 | $3.07M | Buy |
+36,000
| New | +$2.84M | 0.49% | 71 |
|
|
2014
Q3 | – | Sell |
-22,500
| Closed | -$1.03M | – | 101 |
|
|
2014
Q2 | $1.03M | Buy |
+22,500
| New | +$993K | 0.31% | 86 |
|
|
2014
Q1 | – | Sell |
-72,000
| Closed | -$3.07M | – | 96 |
|
|
2013
Q4 | $3.07M | Buy |
+72,000
| New | +$3.03M | 1.2% | 25 |
|
Other funds holding ISRG
Rhenman & Partners Asset Management's ISRG Position: Q2 2026 in Review
Rhenman & Partners Asset Management reduced its Intuitive Surgical (ISRG) stake by 6.4% in Q2 2026, selling an estimated $1.02M and leaving 34,500 shares worth $13.7M. The position accounts for 1.3% of the portfolio, ranked #32.
Rhenman & Partners Asset Management first reported a position in ISRG in Q4 2013 and has held it in 30 quarters since. The position peaked at $33.4M in Q4 2024. 2,254 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.
- Rhenman & Partners Asset Management held 34,500 shares of Intuitive Surgical worth $13.7M as of Q2 2026.
- Rhenman & Partners Asset Management sold 2,346 Intuitive Surgical shares in Q2 2026, an estimated $1.02M.
- Intuitive Surgical made up 1.3% of Rhenman & Partners Asset Management's portfolio in Q2 2026, its #32 holding.
- Rhenman & Partners Asset Management first reported a position in Intuitive Surgical in Q4 2013 and has held it in 30 quarters since.
- Rhenman & Partners Asset Management's Intuitive Surgical position peaked at $33.4M in Q4 2024.
- 2,254 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.
Based on Rhenman & Partners Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.